Bristol-Myers Squibb (BMY) Insider Trading & Ownership $59.10 +0.06 (+0.09%) Closing price 01/30/2025 03:59 PM EasternExtended Trading$59.14 +0.03 (+0.05%) As of 01/30/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Bristol-Myers Squibb (NYSE:BMY) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.09%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$100,046.10Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$38,934.00 Get BMY Insider Trade Alerts Want to know when executives and insiders are buying or selling Bristol-Myers Squibb stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BMY Insider Buying and Selling by Quarter Bristol-Myers Squibb Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/6/2024Virginia FoxxU.S. Congress Member (R-NC)Buy$59.38$1,001 - $15,00011/4/2024Phil M HolzerSVPSell700$55.62$38,934.00 11/1/2024Samit HirawatEVPBuy1,830$54.67$100,046.10 (Data available from 1/1/2013 forward) BMY Insider Trading Activity - Frequently Asked Questions Who is on Bristol-Myers Squibb's Insider Roster? The list of insiders at Bristol-Myers Squibb includes Ann Powell, Christopher S Boerner, David V Elkins, Giovanni Caforio, Karen Murphy Santiago, Phil M Holzer, Robert M Plenge, Rupert Vessey, Samit Hirawat, Sandra Leung, and Theodore R Samuels II. Learn more on insiders at BMY. What percentage of Bristol-Myers Squibb stock is owned by insiders? 0.09% of Bristol-Myers Squibb stock is owned by insiders. Learn more on BMY's insider holdings. Which Bristol-Myers Squibb insiders have been buying company stock? The following insiders have purchased BMY shares in the last 24 months: Christopher S Boerner ($249,609.06), Samit Hirawat ($100,046.10), and Theodore R Samuels II ($423,385.00). How much insider buying is happening at Bristol-Myers Squibb? Insiders have purchased a total of 15,401 BMY shares in the last 24 months for a total of $773,040.16 bought. Which Bristol-Myers Squibb insiders have been selling company stock? The following insiders have sold BMY shares in the last 24 months: Ann Powell ($1,936,900.77), Giovanni Caforio ($17,916,000.00), Phil M Holzer ($38,934.00), Robert M Plenge ($44,754.48), and Rupert Vessey ($3,378,818.10). How much insider selling is happening at Bristol-Myers Squibb? Insiders have sold a total of 320,986 Bristol-Myers Squibb shares in the last 24 months for a total of $23,315,407.35 sold. Which members of congress are trading Bristol-Myers Squibb? Virginia Foxx (R-NC) and Tommy Tuberville (R-AL) have bought shares of Bristol-Myers Squibb in the last year totaling $16,000. Tommy Tuberville (R-AL) has sold shares totaling $8,000. Bristol-Myers Squibb Key ExecutivesDr. Christopher S. Boerner Ph.D. (Age 53)CEO & Chairman Compensation: $3.14MMr. David V. Elkins (Age 56)Executive VP & CFO Compensation: $2.28MMs. Sandra Leung Esq. (Age 63)Executive VP & General Counsel Compensation: $2.58MMr. Samit Hirawat M.D. (Age 55)Executive VP, Chief Medical Officer & Head of Development Compensation: $2.62M1 recent tradesMr. Greg Meyers (Age 51)Executive VP and Chief Digital & Technology Officer Mr. Timothy PowerVP & Head of Investor RelationsMs. Kimberly M. JablonskiChief Compliance & Ethics OfficerMs. Ahn Amanda Poole (Age 49)Executive Vice President & Chief Human Resources Officer Dr. Joseph J. Eiden Jr. (Age 75)Head of Medical Affairs Mr. Adam Lenkowsky (Age 52)Executive VP, Chief Commercialization Officer & Head of U.S. Oncology More Insider Trading Tools from MarketBeat Related Companies Johnson & Johnson Insider Buying AbbVie Insider Buying Merck & Co., Inc. Insider Buying Pfizer Insider Buying Zoetis Insider Buying Royalty Pharma Insider Buying Jazz Pharmaceuticals Insider Buying Corcept Therapeutics Insider Buying Perrigo Insider Buying Supernus Pharmaceuticals Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for Investors This page (NYSE:BMY) was last updated on 1/31/2025 by MarketBeat.com Staff From Our PartnersTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredTrump’s New AI Move Could Trigger Massive Melt UPIn his first week in office, President Trump already revoked President Biden's disastrous AI executive order.....InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bristol-Myers Squibb Please log in to your account or sign up in order to add this asset to your watchlist. Share Bristol-Myers Squibb With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BMY Stock Alerts